When patients are diagnosed with non-melanoma skin cancers like basal cell carcinoma and squamous cell carcinoma, the first questions they ask are typically along the lines of…
- What does this mean?
- How serious is this?
- Is this life threatening?
- What is the survival rate?
- How can this be treated?
That last question tends to be the most important. Luckily, there are many treatment options for non-melanoma skin cancers available that boast great success rates.
These include curettage and electrodesiccation, Mohs surgery, excisional surgery, cryosurgery, photodynamic therapy, laser surgery, topical medications, and radiation.
For decades, Mohs surgery has been considered the gold standard for the treatment of non-melanoma skin cancers. While it does have extremely high rates of success, there is a pretty significant potential downside that many patients would rather avoid.
If the basal cell carcinoma or squamous cell carcinoma is located somewhere on the face, there’s a chance that the surgery can result in serious scarring that requires plastic surgery to repair.
For many older patients, patients on blood thinners, or patients suffering from other medical issues, they’d prefer not to undergo surgery because it may further complicate their current health.
Sensus Healthcare offers another option: the SRT-100. This revolutionary machine utilizes non-surgical methods to treat non-melanoma skin cancers with a 95+% success rate. The SRT-100 uses precisely calibrated doses of superficial radiation therapy to effectively kill the cancer cells.
The benefits of superficial radiation therapy include the following:
- Non-invasive, non-surgical treatment
- No anesthesia
- No cutting, bleeding, or stitching
- No pain
- No downtime or lifestyle restrictions
- No unsightly scarring
- No need for post treatment reconstructive surgeries
- 95+% success rate
If you’d like to learn more about the SRT-100 as an option for treating your patients’ non-melanoma skin cancers, contact Sensus Healthcare today.